Imatinib Impurity 11
|
伊馬替尼雜質(zhì)11
|
404844-11-7
|
3-AMINO-3-(4-BROMOPHENYL)ACRYLONITRILE
|
布南色林雜質(zhì)
|
748807-82-1
|
4-Chlorobenzoylacetonitrile
|
4-氯苯甲酰乙腈(布南色林雜質(zhì))
|
4640-66-8
|
Cycloocta[b]pyridine, 2-(4-ethyl-1-piperazinyl)-5,6,7,8,9,10-hexahydro-4-phenyl-
|
布南色林雜質(zhì)2
|
132810-75-4
|
Linagliptin Impurity S
|
利格列汀雜質(zhì)S
|
668273-74-3
|
Mometasone
|
莫美他松(糠酸莫米松雜質(zhì))
|
105102-22-5
|
Diethyl 2-(2-chloroethyl)propanedioate
|
卡博替尼雜質(zhì)
|
18719-42-1
|
N1-ethyl-N2-(4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridin-2-yl)ethane-1,2-diamine hydrochloride
|
布南色林雜質(zhì)05
|
2243798-59-4
|
Ethanone, 1,1'-cyclobutylidenebis-
|
卡博替尼雜質(zhì)
|
126290-88-8
|
N1,N3-bis(4-fluorophenyl)malonamide(CabozantinibImpurity)
|
N1,N3-雙(4-氟苯基)丙二酰胺(卡博替尼雜質(zhì))
|
1677-29-8
|
2-Chloro-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine
|
2-氯-4-(4-氟苯基)-5,6,7,8,9,10-六氫環(huán)辛烷并[b]吡啶(布南色林雜質(zhì))
|
132813-14-0
|
Cabozantinib impurity 51
|
卡博替尼雜質(zhì)51
|
2354-89-4
|
Blonanserin Impurity I
|
布南色林雜質(zhì)I
|
49860-76-6
|
Cabozantinib Impurity4
|
卡博替尼雜質(zhì)4
|
95932-39-1
|
Cabozantinib impurity 47
|
卡博替尼雜質(zhì)47
|
113136-79-1
|
Cabozantinib Impurity 8
|
卡博替尼雜質(zhì)8
|
918642-61-2
|
Cabozantinib Impurity 6
|
卡博替尼雜質(zhì)6
|
1621681-63-7
|
Cabozantinib Impurity 10
|
卡博替尼雜質(zhì)10
|
2439164-91-5
|
tert-butyl (R)-(1-((4-methylquinazolin-2-yl)methyl)piperidin-3-yl)carbamate
|
利格列汀雜質(zhì)C
|
2514949-81-4
|
Cycloocta[b]pyridin-2-amine, 4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro-
|
布南色林雜質(zhì)12
|
2518376-10-6
|
Formamide, N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-
|
卡博替尼雜質(zhì)
|
190728-28-0
|
1-(phenylaminocarbonyl)cyclopropanecarboxylicacid
|
1-(苯基氨基甲酰基)環(huán)丙烷羧酸(卡博替尼雜質(zhì))
|
145591-80-6
|
Linagliptin Impurity 24
|
利格列汀雜質(zhì)24
|
1418133-47-7
|
Quinoline, 6,7-dimethoxy-4-(4-nitrophenoxy)-
|
卡博替尼雜質(zhì)12
|
190728-24-6
|
Cycloocta[b]pyridine, 4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro-2-(1-piperazinyl)-
|
布南色林雜質(zhì)C
|
132811-84-8
|
Linagliptin Impurity 16
|
利格列汀雜質(zhì)16
|
1791405-13-4
|
N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-N-phenylcyclopropane-1,1-dicarboxamide
|
卡博替尼雜質(zhì)02
|
849221-94-9
|
1,1-Cyclobutanedicarboxylic acid
|
1,1-環(huán)丁基二甲酸(卡博替尼雜質(zhì))
|
5445-51-2
|
Blonanserin Impurity K
|
布朗沙色林雜質(zhì)K(布南色林雜質(zhì))
|
142838-82-2
|
4-(4-Carboxybenzyl)piperazine-1-carboxylic acid tert-butyl ester
|
4-(4-叔丁氧基羰酰)哌嗪甲基苯甲酸(伊馬替尼雜質(zhì))
|
479353-63-4
|
Linagliptin Impurity 29
|
利拉利汀雜質(zhì)29
|
2074688-82-5
|
Imatinib EP Impurity F
|
伊馬替尼EP雜質(zhì) F
|
152460-10-1
|
3-Dimethylamino-1-(N-oxido-4-pyridyl)-2-propen-1-on
|
伊馬替尼雜質(zhì)
|
2387475-37-6
|
Linagliptin Impurity 35
|
利格列汀雜質(zhì)35
|
668273-75-4
|
2-(4-ethylpiperazin-1-yl)-4-(4-(4-ethylpiperazin-1-yl)phenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine
|
布南色林雜質(zhì)A
|
1648791-23-4
|
Cabozantinib Impurity 14
|
卡博替尼雜質(zhì)14
|
1175127-32-8
|
1-Piperazinecarboxaldehyde, 4-ethyl-
|
布南色林雜質(zhì)
|
21863-75-2
|
Blonanserin Impurity 18
|
布南色林雜質(zhì) 18
|
1477480-40-2
|
2-Propenenitrile, 3-amino-3-(3-fluorophenyl)-
|
布南色林雜質(zhì)
|
71682-85-4
|
N-Desmethyl Imatinib
|
N-去甲基伊馬替尼
|
404844-02-6
|
1,4-Bis-[4-[4-Methyl-3-[[4-(pyridin-3-yl)pyriMidin-2-yl]aMino]phenyl]carbaMoyl]benzylpiperazine
|
伊馬替尼雜質(zhì)E
|
1365802-18-1
|
Blonanserin iMpurity
|
布南色林雜質(zhì)
|
132810-83-4
|
Desfluoro Hydroxy Blonanserin
|
布南色林雜質(zhì)
|
132812-29-4
|
1-((4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)carbamoyl)cyclopropane-1-carboxylic acid
|
卡博替尼雜質(zhì)03
|
849217-77-2
|
3-(2-Fluorophenyl)-3-oxopropionitrile
|
2-氟苯甲?;译妫ú寄仙蛛s質(zhì))
|
31915-26-1
|
3-Amino-3-(4-chlorophenyl)prop-2-enenitrile
|
布南色林雜質(zhì)
|
25354-58-9
|
Imatinib Impurity 19
|
伊馬替尼雜質(zhì)19
|
14188-94-4
|
INDEX NAME NOT YET ASSIGNED
|
利格列汀雜質(zhì)
|
2748381-67-9
|
1-((4-Fluorophenyl)carbamoyl)cyclopropanecarboxylicacid
|
1-(4-氟苯基氨基甲?;?環(huán)丙烷羧酸(卡博替尼雜質(zhì))
|
849217-48-7
|
4-((6,7-Dimethoxyquinolin-4-yl)oxy)aniline
|
4-[(6,7-二甲氧基喹啉-4-基)氧]苯胺(卡博替尼中間體)
|
190728-25-7
|
Cabozantinib Impurity 42
|
卡博替尼雜質(zhì)42
|
95262-10-5
|
Cabozantinib Impurity 9
|
卡博替尼雜質(zhì)9
|
1431468-36-8
|
2-chloro-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine 1-oxide
|
布南色林雜質(zhì)08
|
143213-96-1
|
Imatinib EP Impurity C
|
伊馬替尼EP雜質(zhì)C
|
1407124-77-9
|
Imatinib EP Impurity J
|
伊馬替尼EP雜質(zhì)J
|
571186-91-9
|
iMatinib related substance B
|
伊馬替尼進口標(biāo)準(zhǔn)雜質(zhì)B
|
571186-93-1
|
Mometasone Furoate Impurity O
|
糠酸莫米松雜質(zhì)O
|
24916-91-4
|
(Z)-3-Amino-3-(4-fluoro-phenyl)-acrylonitrile
|
布南色林雜質(zhì)
|
55330-46-6
|
Imatinib Impurity 17
|
伊馬替尼雜質(zhì)17
|
1802325-93-4
|
Cabozantinib impurity
|
卡博替尼雜質(zhì)
|
1904529-45-8
|
8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione
|
利拉利汀母核
|
853029-57-9
|
Linagliptin iMpurity G
|
利拉利汀雜質(zhì)G
|
668270-11-9
|
Blonanserin Impurity 10
|
布南色林雜質(zhì)10
|
132810-87-8
|
3-Fluorobenzoylacetonitrile
|
3-氟苯甲酰乙腈(布南色林雜質(zhì))
|
21667-61-8
|
Cabozantinib Impurity 11
|
卡博替尼雜質(zhì)11
|
861345-47-3
|
4-Fluorobenzoylacetonitrile
|
4-氟苯甲酰基乙腈(布南色林雜質(zhì))
|
4640-67-9
|
Cycloocta[b]pyridin-2(1H)-one, 5,6,7,8,9,10-hexahydro-4-phenyl-
|
布南色林雜質(zhì)
|
132812-71-6
|
2 - (ChloracetylaMino)acetophenon
|
利拉利汀雜質(zhì)Q(利格列汀雜質(zhì))
|
6140-11-0
|
Cabozantinib impurity 1
|
卡博替尼雜質(zhì)1
|
748707-58-6
|
4-[(E)-(4-hydroxyphenyl)azo]phenol
|
4,4-二羥基偶氮苯(卡博替尼雜質(zhì))
|
51437-66-2
|
Cabozantinib Impurity 25
|
卡博替尼雜質(zhì)25
|
1247859-37-5
|
Linagliptin Impurity A
|
利格列汀雜質(zhì)A
|
2436762-89-7
|
N-(4-Fluorophenyl)-N'-(4-hydroxyphenyl)cyclopropane-1,1-dicarboxamide(CabozantinibImpurity)
|
N-(4-氟苯基)-N-(4-羥基苯基)環(huán)丙烷-1,1-二羧酰胺(卡博替尼雜質(zhì))
|
849217-60-3
|
Benzenepropanoic acid, 4-fluoro-b-oxo-
|
3-(4-氟苯基)-3-氧代丙酸
|
80646-00-0
|
iMatinib related substance C
|
伊馬替尼進口標(biāo)準(zhǔn)雜質(zhì)C
|
938082-57-6
|
11,17-Difuroate MoMetasone Furoate
|
11,17-二糠酸莫米松(糠酸莫米松雜質(zhì))
|
1370190-33-2
|
Linagliptin Impurity 28
|
利格列汀雜質(zhì)28
|
2074688-84-7
|
Cabozantinib Impurity 5
|
卡博替尼雜質(zhì)5
|
2377278-36-7
|
6-Chloro-1-hydroxibenzotriazol
|
6-氯-1-羥基苯并三氮唑(卡博替尼雜質(zhì))
|
26198-19-6
|
INDEX NAME NOT YET ASSIGNED
|
利格列汀雜質(zhì)
|
2749405-42-1
|
1H-Purine-2,6-dione, 7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-8-[(4-methyl-2-quinazolinyl)methoxy]-1-[(4-methyl-2-quinazolinyl)methyl]-
|
利格列汀雜質(zhì)
|
2469626-53-5
|
Benzoic acid, 4,4'-[1,4-piperazinediylbis(methylene)]bis-, dimethyl ester (9CI)
|
伊馬替尼雜質(zhì)
|
80276-39-7
|
Linagliptin impurity KH-2
|
N-(2-乙?;交?-2-(8-溴-7-(丁-2-炔-1-基)-3-甲基-2,6-二氧代-2,3,6,7-四氫-1H--嘌呤-1-基)乙酰胺(利格列汀雜質(zhì))
|
2279114-31-5
|
Linagliptin Impurity 45
|
利格列汀雜質(zhì)45
|
2463617-43-6
|
2-amino-6-methylbenzenecarboximidamide
|
伊馬替尼雜質(zhì)
|
1694987-11-5
|
3-amino-3-(4-fluorophenyl)propanenitrile
|
3-氨基-3-(4-氟苯基)丙腈(布南色林雜質(zhì))
|
1270488-91-9
|
N-Depiperidin-3-amine Linagliptin Dimer
|
N-去哌啶-3-胺 利格列汀二聚體(利格列汀雜質(zhì))
|
2253964-98-4
|
Tert-butyl4-(4-(methoxycarbonyl)benzyl)piperazine-1-carboxylate
|
4-(4-(甲氧基羰基)芐基)哌嗪-1-羧酸叔丁酯(伊馬替尼雜質(zhì))
|
844891-11-8
|
(E)-3-AMINO-3-(4-CHLOROPHENYL)-2-PROPENENITRILE;(2E)-3-amino-3-(4-chlorophenyl)prop-2-enenitrile
|
3-氨基-3-(4-氯苯基)丙-2-烯腈(布南色林雜質(zhì))
|
107840-43-7
|
Cycloocta[b]pyridine, 2-chloro-4-(4-chlorophenyl)-5,6,7,8,9,10-hexahydro-
|
布南色林雜質(zhì) 26(14)
|
132813-22-0
|
Cyclobutanecarboxylic acid, 1-[[(4-fluorophenyl)amino]carbonyl]-
|
卡博替尼雜質(zhì)21
|
849217-49-8
|
6,7-Quinolinediol, 4-chloro-
|
4-氯-6,7-二羥基喹啉(卡博替尼雜質(zhì))
|
1256637-72-5
|
Cycloocta[b]pyridin-2(1H)-one, 4-(2-fluorophenyl)-5,6,7,8,9,10-hexahydro-
|
布南色林雜質(zhì)
|
132812-74-9
|
Benzamide, 4-[[4-[4-[(4-methyl-1-piperazinyl)methyl]benzoyl]-1-piperazinyl]methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-
|
伊馬替尼雜質(zhì)
|
2410195-23-0
|
Diazene, bis(4-fluorophenyl)-, (Z)- (9CI)
|
卡博替尼雜質(zhì)
|
51789-00-5
|
Blonanserin Impurity 15
|
布南色林雜質(zhì)15
|
132813-16-2
|
Acetamide, N-(2-acetylphenyl)-2,2-dichloro-
|
利格列汀雜質(zhì)
|
6140-12-1
|
6-Chloro-1H-cinnolin-4-one
|
卡博替尼雜質(zhì)
|
876-89-1
|
3-(4-fluorophenyl)-3-oxopropanamide
|
3-(4-氟苯基)-3-氧代丙酰胺
|
671188-82-2
|
Cycloocta[b]pyridine, 2-chloro-4-(3-fluorophenyl)-5,6,7,8,9,10-hexahydro-
|
布南色林雜質(zhì) 28(16)
|
132813-15-1
|